Fresenius Medical Care AG (BIT:1FME)
Italy
· Delayed Price · Currency is EUR | Market Cap | 10.85B |
| Revenue (ttm) | 19.63B |
| Net Income (ttm) | 978.37M |
| Shares Out | n/a |
| EPS (ttm) | 3.36 |
| PE Ratio | 11.09 |
| Forward PE | 9.61 |
| Dividend | 1.44 (3.77%) |
| Ex-Dividend Date | May 23, 2025 |
| Volume | n/a |
| Average Volume | 134 |
| Open | n/a |
| Previous Close | 38.23 |
| Day's Range | n/a |
| 52-Week Range | 35.67 - 53.42 |
| Beta | n/a |
| RSI | 48.45 |
| Earnings Date | Feb 24, 2026 |
About Fresenius Medical Care AG
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospital... [Read more]
Financial Performance
In 2025, Fresenius Medical Care AG's revenue was 19.63 billion, an increase of 1.51% compared to the previous year's 19.34 billion. Earnings were 978.37 million, an increase of 81.88%.
Financial StatementsNews
Fresenius Medical Care AG (FMS) Q4 2025 Earnings Call Transcript
Fresenius Medical Care AG (FMS) Q4 2025 Earnings Call Transcript
Fresenius Medical Care AG (FMS) Full Year 2025 Earnings Call Highlights: Record Profitability ...
Fresenius Medical Care AG (FMS) Full Year 2025 Earnings Call Highlights: Record Profitability and Strategic Initiatives Propel Growth
EQS-CMS: Fresenius Medical Care AG : Release according to Article 50 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Post-admission Duties announcement: Fresenius Medical Care AG / Third country release according to Article 50 Para. 1, No. 2 of the WpHG [the German Securities Trading Act] Fresenius Medical Care ...
Full Year 2025 Fresenius Medical Care AG Earnings Call Transcript
Full Year 2025 Fresenius Medical Care AG Earnings Call Transcript
Fresenius Medical Care AG 2025 Q4 - Results - Earnings Call Presentation
Fresenius Medical Care AG (FMS) Trading Down 6.47% on Feb 24
Fresenius Medical Care AG (FMS) Trading Down 6.47% on Feb 24
Fresenius Medical Care Shares Fall 10% After 2026 Outlook Update
Fresenius Medical Care Shares Fall 10% After 2026 Outlook Update
Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band
Strong organic revenue growth1 in 2025 of 8% driven by all operating segments Driven by an exceptional Q4, full year operating income2 growth of 27% reached top end of financial outlook, resulting in ...
Fresenius Medical Care Shares Drop After Outlook, U.S. Performance Underwhelms
Shares in the dialysis specialist were down 7.1% in European midday trade, with the decline erasing gains since the start of 2026.
Fresenius Medical Care: Q4 Earnings Insights
Fresenius Medical Care (NYSE: FMS) released its Q4 earnings on Tuesday, February 24, 2026 at 06:09 AM. Here's what's important from the earnings announcement. Earnings Fresenius Medical Care beat est...
Earnings Scheduled For February 24, 2026
Companies Reporting Before The Bell • China Yuchai Intl (NYSE: CYD) is expected to report earnings for its Fiscal Year 2025. • Armstrong World Indus (NYSE: AWI) is likely to report quarterly earning...
Fresenius Medical Care (FMS) Reports Q4 Results and Future Outlook
Fresenius Medical Care (FMS) Reports Q4 Results and Future Outlook
Fresenius Medical Care Q4 Earnings Surge
BAD HOMBURG VOR DER HOEHE (dpa-AFX) - Fresenius Medical Care AG (FME.DE, FMS), a German provider of products and services for patients with renal diseases, on Tuesday reported a surge in earnings ...
Fresenius Medical Care Non-GAAP EPS of Є1.44, revenue of Є5.07B; introduces FY26 and long-term outlook
Fresenius Medical Care press release (FMS): Q4 Non-GAAP EPS of Є1.44. Revenue of Є5.07B (-0.2% Y/Y).
Fresenius Medical Care's operating profit surges in Q4
Fresenius Medical Care reported a sharp rise in fourth‑quarter operating income on Tuesday, helped by accelerating cost savings and favourable reimbursement effects.
Fresenius Medical Care Q4 2025 Earnings Preview
Uncovering Potential: Fresenius Medical Care's Earnings Preview
Fresenius Medical Care (NYSE: FMS) is set to give its latest quarterly earnings report on Tuesday, 2026-02-24. Here's what investors need to know before the announcement. Analysts estimate that Frese...
Fresenius Medical Care: Low Confidence On Growth Acceleration Limits Upside
EQS-PVR: Fresenius Medical Care AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: Fresenius Medical Care AG Fresenius Medical Care AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Eu...
Fresenius Medical Care AG (FMS) Shares Down 3.69% on Jan 20
Fresenius Medical Care AG (FMS) Shares Down 3.69% on Jan 20
EQS-CMS: Fresenius Medical Care AG : Release of a capital market information
EQS Post-admission Duties announcement: Fresenius Medical Care AG / Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014 Fresenius Medical Care AG : Release of a capital marke...
EQS-PVR: Fresenius Medical Care AG: Publication of acquisition or disposal in respect of own shares according Sec. 40 para. 1 sent. 2 WpHG
EQS Voting Rights Announcement: Fresenius Medical Care AG Fresenius Medical Care AG: Publication of acquisition or disposal in respect of own shares according Sec. 40 para. 1 sent. 2 WpHG 16.01.2026 /...
Fresenius Medical Care AG at JPMorgan Healthcare Conference Transcript
Fresenius Medical Care AG at JPMorgan Healthcare Conference Transcript
Fresenius Medical Care AG (FMS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Fresenius Medical Care AG (FMS) 44th Annual J.P. Morgan Healthcare Conference January 13, 2026 2:15 PM ESTCompany ParticipantsHelen Giza - Chair of...
Fresenius Medical Care AG (FMS) Stock Price Down 3.82% on Jan 13
Fresenius Medical Care AG (FMS) Stock Price Down 3.82% on Jan 13